0
Signin
countryflagUK

8082-737-676

0R15 7793.0 0.1028% 0R1E 7575.0 -1.8782% 0M69 None None% 0R2V 174.0 1.6058% 0QYR 1387.5 0.7991% 0QYP 397.5 0.7605% 0LCV 137.1211 0.3815% 0RUK None None% 0RYA 1752.0 0.0% 0RIH 165.6 0.3941% 0RIH 164.7 -0.5435% 0R1O 181.75 10110.6742% 0R1O None None% 0QFP None None% 0M2Z 298.95 0.302% 0VSO None None% 0R1I None None% 0QZI 434.5 -0.344% 0QZ0 220.0 0.0% 0NZF None None%

Sareum Hldgs Plc

Healthcare GB SAR

25.25GBP
-2.0(7.34%)

Last update at 2024-05-02T16:07:00Z

Day Range

25.0027.00
LowHigh

52 Week Range

50.00149.00
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -4.02500M -2.57900M -1.71788M -1.12012M -1.68237M
Minority interest - - - - -
Net income -3.19200M -2.17200M -1.50038M -0.98591M -1.45246M
Selling general administrative 4.05M 2.58M 1.88M 1.14M 1.68M
Selling and marketing expenses - - - - -
Gross profit - - - 0.05M -
Reconciled depreciation 0.00100M 0.00200M 0.00109M 0.00064M 0.00800M
Ebit -4.04800M -2.58000M -1.71797M -1.09495M -1.68237M
Ebitda - -2.57500M -1.70293M -1.09431M -1.67437M
Depreciation and amortization - 0.00500M 0.02M 0.00064M 0.00800M
Non operating income net other - - - - -
Operating income -4.04800M -2.58000M -1.71797M -1.12468M -1.67644M
Other operating expenses - 2.58M 1.70M 1.14M 1.68M
Interest expense - 0.00100M 0.01M 0.00593M 0.00593M
Tax provision -0.83300M -0.40700M -0.21750M -0.13421M -0.22990M
Interest income 0.04M 0.00100M 0.00009M 0.00455M 0.00409M
Net interest income 0.04M 0.00100M 0.00009M 0.00455M 0.00409M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.83300M -0.40700M -0.21750M -0.13421M -0.22990M
Total revenue 0.00000M 0.00000M 0.00000M 0.05M 0.00000M
Total operating expenses 4.05M 2.58M 1.70M 1.14M 1.68M
Cost of revenue - - - - -
Total other income expense net - 0.00100M 0.00009M -0.02517M -0.00593M
Discontinued operations - - - - -
Net income from continuing ops -3.19200M -2.17200M -1.50038M -0.98591M -1.45246M
Net income applicable to common shares -3.19200M -2.17200M -1.50038M -0.98591M -1.45246M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 2.02M 4.79M 3.08M 2.00M 1.24M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.50M 0.50M 0.37M 0.20M 0.29M
Total liab 0.87M 0.46M 0.28M 0.20M 0.15M
Total stockholder equity 1.15M 4.33M 2.80M 1.80M 1.09M
Deferred long term liab - - - - -
Other current liab 0.17M 0.07M 0.18M 0.09M 0.05M
Common stock 0.85M 0.85M 0.83M 0.81M 0.72M
Capital stock 0.85M 0.85M 0.83M 0.81M 0.72M
Retained earnings -20.96200M -17.77000M -15.63500M -14.18068M -13.19476M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.99M 4.26M 2.69M 1.80M 0.92M
Cash and equivalents - - - - -
Total current liabilities 0.87M 0.46M 0.28M 0.20M 0.15M
Current deferred revenue - - - - -
Net debt -0.99400M -4.26100M -2.68616M -1.80286M -0.91934M
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 21.26M 21.25M 17.60M 15.18M 13.57M
Property plant equipment 0.00100M 0.00200M 0.00154M 0.00263M -
Total current assets 1.97M 4.76M 3.05M 2.00M 1.21M
Long term investments - - - - 0.03M
Net tangible assets 1.15M 4.33M 2.80M 1.80M 1.09M
Short term investments - - 2.69M 1.79M 0.91M
Net receivables 0.90M 0.46M 0.32M 0.14M 0.24M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.69M 0.39M 0.10M 0.20M 0.15M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.01053M -0.00989M
Additional paid in capital - - - - -
Common stock total equity - - - 0.81M 0.72M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.05M 0.02M 0.03M 0.00163M 0.03M
Deferred long term asset charges - - - - -
Non current assets total 0.05M 0.03M 0.03M 0.00426M 0.03M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.04100M -0.00200M -0.03795M 0.00129M 0.00409M
Change to liabilities 0.41M 0.17M 0.09M 0.05M -0.03653M
Total cashflows from investing activities - -0.00200M -0.03786M 0.00129M 0.00409M
Net borrowings - - - - -
Total cash from financing activities 3.71M 3.71M 2.49M 1.70M 0.80M
Change to operating activities - 0.23M 0.23M 0.23M 0.23M
Net income -4.02400M -2.58000M -1.71788M -1.12012M -1.68237M
Change in cash -3.26700M 1.57M 0.88M 0.88M -0.45593M
Begin period cash flow 4.26M 2.69M 1.80M 0.92M 1.38M
End period cash flow 0.99M 4.26M 2.69M 1.80M 0.92M
Total cash from operating activities -3.26700M -2.13100M -1.57066M -0.81309M -1.26323M
Issuance of capital stock 0.00000M 3.71M 2.49M 1.70M 0.80M
Depreciation 0.00100M 0.00200M 0.00109M 0.00064M 0.00800M
Other cashflows from investing activities 0.04M 0.00100M 0.00009M 0.00455M 0.00409M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.06500M 0.06M -0.08755M -0.00029M 0.07M
Sale purchase of stock - - 2.49M 1.70M 0.80M
Other cashflows from financing activities -0.04100M -0.00200M -0.03786M 0.00129M 0.00421M
Change to netincome -0.42200M -0.18800M -0.06943M 0.12M 0.14M
Capital expenditures 0.00300M 0.00300M 0.00326M 0.00326M 0.00326M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.35M 0.23M -0.00193M 0.05M 0.04M
Stock based compensation - - - 0.12M 0.12M
Other non cash items 0.41M 0.22M 0.15M 0.26M -0.00409M
Free cash flow -3.26700M -2.13400M -1.57066M -0.81635M -1.26323M

Fundamentals

  • Previous Close 27.25
  • Market Cap43.91M
  • Volume540772
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.04700M
  • Revenue TTM0.05M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.05M
  • Diluted EPS TTM-0.05

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SAR
Sareum Hldgs Plc		 -2.0 7.34% 25.25 - - 4491.97 35.04 4892.31 -9.7372
ONT
Oxford Nanopore Technologies Ltd		 5.20 5.14% 106.40 - - 10.88 2.75 8.77 -16.7946
GNS
Genus PLC		 48.00 2.77% 1784.00 42.59 25.71 2.08 2.46 2.31 16.39
PRTC
PureTech Health plc		 -2.0 0.93% 214.00 - - 35.55 1.04 95.87 -4.5333
AVCT
Avacta Group PLC		 -0.25 0.53% 46.50 - - 23.19 14.78 20.75 -10.4566

Reports Covered

Stock Research & News

View All

Profile

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes TYK2/JAK1 kinase, which is in preclinical stage; Checkpoint Kinase 1, which has completed clinical phase II; and FLT3+Aurora kinase, which is in preclinical stage. The company was founded in 2003 and is headquartered in Cambridge, the United Kingdom.

Sareum Hldgs Plc

Langford Arch, Cambridge, United Kingdom, CB22 3FX

Key Executives

Name Title Year Born
Dr. Tim J. Mitchell Ph.D. Founder, CEO & Exec. Director 1960
Dr. John C. Reader Ph.D. Founder, Chief Scientific Officer & Exec. Director 1967
Mr. Anthony Bunn F.C.M.A., FCMA Sec. NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions